| 07/08/2026 5:08 PM | Janus Henderson Group (1274173) Filed by Privacore PCAAM Alternative Income Fund (2017579) Subject | Form SCHEDULE 13G | |
| 07/08/2026 5:08 PM | Janus Henderson Group (1274173) Filed by Privacore PCAAM Alternative Growth Fund (2017577) Subject | Form SCHEDULE 13G | |
| 07/08/2026 5:09 PM | Janus Henderson Group (1274173) Filed by Privacore VPC Asset Backed Credit Fund (2066579) Subject | Form SCHEDULE 13G | |
| 07/08/2026 4:43 PM | Jade Biosciences, Inc. (1798749) Subject Jade Biosciences, Inc. (1798749) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 07/08/2026 4:44 PM | Biohaven Ltd. (1935979) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 07/06/2026 11:15 PM | Janus Henderson Group (1274173) Filer | Form EFFECT | |
| 07/02/2026 8:01 PM | Frank Joshua D. (1422599) Reporting Janus Henderson Group (1274173) Issuer TRIAN FUND MANAGEMENT, L.P. (1345471) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 8:02 PM | Baldwin Brian M (1728954) Reporting Janus Henderson Group (1274173) Issuer TRIAN FUND MANAGEMENT, L.P. (1345471) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 7:28 PM | Janus Henderson Group (1274173) Subject MASSACHUSETTS MUTUAL LIFE INSURANCE CO (225602) Filed by | Form SCHEDULE 13D/A | |
| 07/02/2026 7:07 PM | Janus Henderson Group (1274173) Issuer PODZOROV MEGAN (2048891) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 7:09 PM | CRAWFORD BERG (2025561) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for JHG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Janus Henderson Group and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/02/2026 7:11 PM | GREWAL SUKHDEEP SINGH (2127478) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 7:12 PM | CASSIDY WILLIAM B (2044423) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 7:16 PM | Janus Henderson Group (1274173) Issuer Seidman Leslie (1595268) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 7:17 PM | Janus Henderson Group (1274173) Issuer ROSENBERG MICHELLE (1898845) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 6:54 PM | Dibadj Ali (1837149) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 6:56 PM | CASSADAY JOHN M (1308732) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 6:57 PM | Janus Henderson Group (1274173) Issuer Sheehan Anne (1776285) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 7:00 PM | Janus Henderson Group (1274173) Issuer Quirk Alison A. (1485499) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 7:01 PM | DOLAN KEVIN B (1897219) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 7:02 PM | Janus Henderson Group (1274173) Issuer SEYMOUR JACKSON ANGELA (1899142) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 7:03 PM | DESAI KALPANA (1899214) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 7:06 PM | FLOOD EUGENE JR (1598139) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 6:50 PM | FOGO GEORGINA (1899144) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 10:26 AM | Janus Henderson Group (1274173) Subject NEW YORK STOCK EXCHANGE LLC (876661) Filed by | Form 25-NSE | |
| 06/30/2026 4:29 PM | Janus Henderson Group (1274173) Subject TRIAN FUND MANAGEMENT, L.P. (1345471) Filed by | Form SCHEDULE 13D/A | |
| 06/30/2026 4:14 PM | Janus Henderson Group (1274173) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/30/2026 4:16 PM | Janus Henderson Group (1274173) Subject | Form SC 13E3/A | |
| 06/30/2026 4:18 PM | Janus Henderson Group (1274173) Filer | Form POS AM | |
| 06/30/2026 4:19 PM | Janus Henderson Group (1274173) Filer | Form S-8 POS | |
| 06/30/2026 4:20 PM | Janus Henderson Group (1274173) Filer | Form S-8 POS | |
| 06/30/2026 4:20 PM | Janus Henderson Group (1274173) Filer | Form S-8 POS | |
| 06/23/2026 4:28 PM | Janus Henderson Group (1274173) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/18/2026 7:57 AM | Janus Henderson Group (1274173) Subject TRIAN FUND MANAGEMENT, L.P. (1345471) Filed by | Form SCHEDULE 13D/A | |
| 06/18/2026 8:02 AM | Janus Henderson Group (1274173) Subject | Form SC 13E3/A | |
| 06/18/2026 7:44 AM | Janus Henderson Group (1274173) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/05/2026 11:56 AM | Immix Biopharma, Inc. (1873835) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 06/05/2026 11:56 AM | Cellectar Biosciences, Inc. (1279704) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G | |
| 06/02/2026 5:07 AM | Janus Henderson Group (1274173) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 1:07 PM | Janus Henderson Group (1274173) Filer | Form 13F-HR/A | |
| 05/15/2026 11:37 AM | Biohaven Ltd. (1935979) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free |
| 05/15/2026 11:37 AM | IDEAYA Biosciences, Inc. (1676725) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:37 AM | Janus Henderson Group (1274173) Filed by MADRIGAL PHARMACEUTICALS, INC. (1157601) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:37 AM | Janus Henderson Group (1274173) Filed by Maze Therapeutics, Inc. (1842295) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:38 AM | Janus Henderson Group (1274173) Filed by Vaxcyte, Inc. (1649094) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:38 AM | Immix Biopharma, Inc. (1873835) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:38 AM | Jade Biosciences, Inc. (1798749) Subject Jade Biosciences, Inc. (1798749) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:38 AM | Janus Henderson Group (1274173) Filed by Janux Therapeutics, Inc. (1817713) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:38 AM | Janus Henderson Group (1274173) Filed by Lantheus Holdings, Inc. (1521036) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:38 AM | Janus Henderson Group (1274173) Filed by Olema Pharmaceuticals, Inc. (1750284) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:39 AM | Janus Henderson Group (1274173) Filed by Protara Therapeutics, Inc. (1359931) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:39 AM | Janus Henderson Group (1274173) Filed by PTC THERAPEUTICS, INC. (1070081) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:50 AM | Janus Henderson Group (1274173) Filed by Tyra Biosciences, Inc. (1863127) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:36 AM | Ascendis Pharma A/S (1612042) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:36 AM | BEL FUSE INC /NJ (729580) Subject BEL FUSE INC /NJ (729580) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:36 AM | BridgeBio Pharma, Inc. (1743881) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:36 AM | BRIGHT MINDS BIOSCIENCES INC. (1827401) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:36 AM | BRIGHT MINDS BIOSCIENCES INC. (1827401) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:36 AM | Dyne Therapeutics, Inc. (1818794) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:36 AM | Forte Biosciences, Inc. (1419041) Subject Forte Biosciences, Inc. (1419041) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:37 AM | Gildan Activewear Inc. (1061894) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:37 AM | GLAUKOS Corp (1192448) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 10:42 AM | COLLEGIUM PHARMACEUTICAL, INC (1267565) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G | |
| 05/15/2026 10:42 AM | Edgewise Therapeutics, Inc. (1710072) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G | |
| 05/15/2026 10:42 AM | Janus Henderson Group (1274173) Filed by Stride, Inc. (1157408) Subject | Form SCHEDULE 13G | |
| 05/15/2026 10:43 AM | Janus Henderson Group (1274173) Filed by Tarsus Pharmaceuticals, Inc. (1819790) Subject | Form SCHEDULE 13G | |
| 05/15/2026 10:43 AM | Bicara Therapeutics Inc. (2023658) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G | |
| 05/15/2026 10:43 AM | Janus Henderson Group (1274173) Filed by Longeveron Inc. (1721484) Subject | Form SCHEDULE 13G | |
| 05/15/2026 10:43 AM | Janus Henderson Group (1274173) Filed by Minerva Neurosciences, Inc. (1598646) Subject | Form SCHEDULE 13G | |
| 05/15/2026 10:23 AM | Janus Henderson Group (1274173) Filed by SS&C Technologies Holdings Inc (1402436) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 10:23 AM | Janus Henderson Group (1274173) Filed by Xenon Pharmaceuticals Inc. (1582313) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 10:23 AM | Janus Henderson Group (1274173) Filed by Revolution Medicines, Inc. (1628171) Subject Revolution Medicines, Inc. (1628171) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 10:23 AM | Janus Henderson Group (1274173) Filed by OSI SYSTEMS INC (1039065) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 10:23 AM | ARDELYX, INC. (1437402) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 10:24 AM | Dayforce, Inc. (1725057) Subject Dayforce, Inc. (1725057) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/14/2026 6:35 PM | Baldwin Brian M (1728954) Reporting Janus Henderson Group (1274173) Issuer TRIAN FUND MANAGEMENT, L.P. (1345471) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 6:36 PM | Frank Joshua D. (1422599) Reporting Janus Henderson Group (1274173) Issuer TRIAN FUND MANAGEMENT, L.P. (1345471) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 6:37 PM | Janus Henderson Group (1274173) Subject TRIAN FUND MANAGEMENT, L.P. (1345471) Filed by | Form SCHEDULE 13D/A | |
| 05/13/2026 7:23 PM | Janus Henderson Group (1274173) Issuer Sheehan Anne (1776285) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 7:27 PM | DOLAN KEVIN B (1897219) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 7:28 PM | DESAI KALPANA (1899214) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 7:34 PM | FLOOD EUGENE JR (1598139) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 7:14 PM | CASSADAY JOHN M (1308732) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 6:59 PM | Janus Henderson Group (1274173) Issuer SEYMOUR JACKSON ANGELA (1899142) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 7:06 PM | Janus Henderson Group (1274173) Issuer Quirk Alison A. (1485499) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 4:38 PM | Janus Henderson Group (1274173) Issuer Seidman Leslie (1595268) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2026 7:02 PM | Janus Henderson Group (1274173) Subject TRIAN FUND MANAGEMENT, L.P. (1345471) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/08/2026 3:30 PM | Janus Henderson Group (1274173) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/08/2026 3:32 PM | Janus Henderson Group (1274173) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/07/2026 10:29 AM | Adagene Inc. (1818838) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G | |
| 05/07/2026 10:29 AM | Janus Henderson Group (1274173) Filed by SOLENO THERAPEUTICS INC (1484565) Subject | Form SCHEDULE 13G/A | |
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad) The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings.
Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds.
If any of these are in your portfolio, now is the time to review your positions. See the 5 stocks to avoid |
| 04/17/2026 8:00 AM | Janus Henderson Group (1274173) Filer | Form ARS | |
| 04/17/2026 8:00 AM | Janus Henderson Group (1274173) Filer | Form DEF 14A | |
| 04/17/2026 8:00 AM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 04/17/2026 7:04 AM | Janus Henderson Group (1274173) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/13/2026 4:15 PM | Janus Henderson Group (1274173) Subject | Form SC 13E3/A | |
| 04/09/2026 3:05 PM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 04/07/2026 3:27 PM | Janus Henderson Group (1274173) Filed by ProMIS Neurosciences Inc. (1374339) Subject | Form SCHEDULE 13G | |
| 04/07/2026 2:48 PM | 4D Molecular Therapeutics, Inc. (1650648) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 04/06/2026 5:35 PM | GREWAL SUKHDEEP SINGH (2127478) Reporting Janus Henderson Group (1274173) Issuer | Form 3 Initial statement of beneficial ownership of securities | |